CD274 and neoplasm: Here, we review recent studies exploring the PD-L1 expression or mutational load of tumor tissues as well as the frequency and phenotype of tumor-infiltrating or blood-circulating immune cells in tumor patients prior to and during checkpoint inhibitor therapy.